Published in Clin Exp Immunol on October 01, 1991
Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative responses to chlamydial antigens compared with those of persistently diseased controls. Infect Immun (1995) 1.27
Cell-mediated immunity to Chlamydia pneumoniae measured as lymphocyte blast transformation in vitro. Infect Immun (1993) 1.04
Cell-mediated immune response during primary Chlamydia pneumoniae infection. Infect Immun (2000) 0.84
Current problems of perinatal Chlamydia trachomatis infections. J Immune Based Ther Vaccines (2004) 0.75
Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes. Proc Natl Acad Sci U S A (1988) 6.54
Modification of the microimmunofluorescence test to provide a routine serodiagnostic test for chlamydial infection. J Clin Pathol (1977) 6.48
Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis. J Immunol (1987) 5.64
Blinding and non-blinding trachoma: assessment of intensity of upper tarsal inflammatory disease and disabling lesions. Bull World Health Organ (1975) 5.58
Are chlamydial infections the most prevalent venereal disease? JAMA (1975) 4.79
Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein. J Exp Med (1989) 4.25
High-resolution mapping of serovar-specific and common antigenic determinants of the major outer membrane protein of Chlamydia trachomatis. J Exp Med (1988) 3.55
Chlamydial disease pathogenesis. Ocular hypersensitivity elicited by a genus-specific 57-kD protein. J Exp Med (1989) 3.03
Trachoma vaccine studies in monkeys. Am J Ophthalmol (1967) 2.65
Pathogenesis of trachoma: the stimulus for inflammation. J Immunol (1987) 2.34
Ocular delayed hypersensitivity: a pathogenetic mechanism of chlamydial-conjunctivitis in guinea pigs. Proc Natl Acad Sci U S A (1986) 2.24
Cellular immune response during uncomplicated genital infection with Chlamydia trachomatis in humans. Infect Immun (1981) 2.03
Chlamydia trachomatis-induced production of interleukin-1 by human monocytes. Infect Immun (1989) 1.58
Gamma interferon-mediated cytotoxicity related to murine Chlamydia trachomatis infection. Infect Immun (1988) 1.56
Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection. Infect Immun (1989) 1.54
Field trial of a monovalent and of a bivalent mineral oil adjuvant trachoma vaccine in Taiwan school children. Am J Ophthalmol (1967) 1.43
Trachoma vaccine field trials in The Gambia. J Hyg (Lond) (1969) 1.33
Human immune response and Chlamydia trachomatis infection. Rev Infect Dis (1985) 1.10
Sensitivity of mitomycin-C treated McCoy cells for isolation of Chlamydia trachomatis from genital specimens. Eur J Clin Microbiol (1987) 1.07
Studies on trachoma. V. Clinical observations in a field trial of bivalent trachoma vaccine at three dosage levels in Saudi Arabia. Am J Trop Med Hyg (1966) 0.98
Immune mechanisms in chlamydial eye infection: cellular immune responses in chronic and acute disease. J Infect Dis (1984) 0.97
Antichlamydial specificity of conjunctival lymphocytes during experimental ocular infection. Infect Immun (1989) 0.87
Detection of Chlamydia (Bedsonia) in certain infections of man. I. Laboratory procedures: comparison of yolk sac and cell culture for detection and isolation. J Infect Dis (1969) 16.47
Modification of the microimmunofluorescence test to provide a routine serodiagnostic test for chlamydial infection. J Clin Pathol (1977) 6.48
Home births in England and Wales, 1979: perinatal mortality according to intended place of delivery. Br Med J (Clin Res Ed) (1984) 4.91
Infection by Bedsoniae and the possibility of spurious isolation. 2. Genital infection, disease of the eye, Reiter's disease. Am J Ophthalmol (1967) 4.73
High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. Genome Res (2000) 4.55
Chlamydial infection. Results of micro-immunofluorescence tests for the detection of type-specific antibody in certain chlamydial infections. Br J Vener Dis (1972) 4.50
Ethics approval for a national postal survey: recent experience. BMJ (1995) 3.59
Rapid diagnosis of chlamydial infection of the cervix. Br J Vener Dis (1978) 3.35
Structural comparison of two nontandemly repeated yeast glyceraldehyde-3-phosphate dehydrogenase genes. J Biol Chem (1980) 3.35
Antibodies to Chlamydia trachomatis in acute salpingitis. Br J Vener Dis (1979) 3.32
The primary structures of two yeast enolase genes. Homology between the 5' noncoding flanking regions of yeast enolase and glyceraldehyde-3-phosphate dehydrogenase genes. J Biol Chem (1981) 3.25
The primary structure of a glyceraldehyde-3-phosphate dehydrogenase gene from Saccharomyces cerevisiae. J Biol Chem (1979) 2.96
Urethritis due to Chlamydia trachomatis. Br J Vener Dis (1977) 2.91
Chlamydia trachomatis and Neisseria gonorrhoeae infections in women attending inner city general practices. Br Med J (Clin Res Ed) (1983) 2.83
Multiple factors bind the upstream activation sites of the yeast enolase genes ENO1 and ENO2: ABFI protein, like repressor activator protein RAP1, binds cis-acting sequences which modulate repression or activation of transcription. Mol Cell Biol (1990) 2.79
Who is speaking for children and adolescents and for their health at the policy level? BMJ (2000) 2.75
Targeted deletion of a yeast enolase structural gene. Identification and isolation of yeast enolase isozymes. J Biol Chem (1982) 2.53
Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J Infect Dis (2001) 2.50
Should there be a trial of home versus hospital delivery in the United Kingdom? BMJ (1996) 2.46
Infection by TRIC agent and other members of the Bedsonia group; with a note on Reiter's disease. II. Ophthalmia neonatorum due to TRIC agent. Trans Ophthalmol Soc U K (1966) 2.46
A simple method for the solubilisation of reduced NBT, and its use as a colorimetric assay for activation of human macrophages by gamma-interferon. J Immunol Methods (1985) 2.38
Isolation of chlamydia from the urethra of a woman. Br Med J (1972) 2.36
Endotoxin-induced serum factor kills malarial parasites in vitro. Infect Immun (1981) 2.30
How well are parent held records kept and completed? Br J Gen Pract (1991) 2.26
Rapid serological test for diagnosis of chlamydial ocular infections. Br J Ophthalmol (1978) 2.25
Short term increases in mortality during heatwaves. Nature (1976) 2.16
Treatment of TRIC infection of the eye with rifampicin or chloramphenicol. Br J Ophthalmol (1977) 2.14
The GCR1 gene encodes a positive transcriptional regulator of the enolase and glyceraldehyde-3-phosphate dehydrogenase gene families in Saccharomyces cerevisiae. Mol Cell Biol (1987) 2.14
Isolation and identification of yeast messenger ribonucleic acids coding for enolase, glyceraldehyde-3-phosphate dehydrogenase, and phosphoglycerate kinase. Biochemistry (1978) 2.09
Perinatal mortality. Lancet (1979) 2.06
Triple-culture tests for diagnosis of chlamydial infection of the female genital tract. Sex Transm Dis (1985) 2.03
Relationship between IFN-gamma and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non-BCG-vaccinated young adults in Northern Malawi. Int J Tuberc Lung Dis (2001) 2.02
Daily mortality and environment in English conurbations. II. Deaths during summer hot spells in greater London. Environ Res (1978) 1.98
Immunological classification of TRIC agents and of some recently isolated LGV agents by the micro-immunofluorescence test. Br J Vener Dis (1972) 1.95
Relation of TRIC agent to "non-specific genital infection". Br J Vener Dis (1966) 1.94
Transcription of the constitutively expressed yeast enolase gene ENO1 is mediated by positive and negative cis-acting regulatory sequences. Mol Cell Biol (1987) 1.93
Expression, Glycosylation, and Secretion of an Aspergillus Glucoamylase by Saccharomyces cerevisiae. Science (1985) 1.88
Maintenance chemotherapy for anaplastic small cell carcinoma of the bronchus: a randomised, controlled trial. Cancer Chemother Pharmacol (1986) 1.87
Differential expression of the three yeast glyceraldehyde-3-phosphate dehydrogenase genes. J Biol Chem (1985) 1.86
Adverse outcome of pregnancy and the quality of obstetric care. Lancet (1984) 1.84
Recent trends in the incidence of multiple births and associated mortality in England and Wales. Arch Dis Child Fetal Neonatal Ed (1996) 1.83
Child health services in the community: making them work. Br Med J (Clin Res Ed) (1986) 1.83
Chlamydial infections in neonates and older children. Br Med Bull (1983) 1.83
Chlamydia and non-specific urethritis. Br Med J (1972) 1.82
Characterization of a further microimmunofluorescence serotype of Chlamydia: TRIC type G. Br J Vener Dis (1973) 1.82
Killing of human malaria parasites by macrophage secretory products. Infect Immun (1984) 1.76
Killing of blood-stage murine malaria parasites by hydrogen peroxide. Infect Immun (1983) 1.74
Development of chronic conjunctivitis with scarring and pannus, resembling trachoma, in guinea-pigs. Br J Ophthalmol (1980) 1.74
Isolation of TRIC agent (Chlamydia) in irradiated McCoy cell culture from endemic trachoma in field studies in Iran. Comparison with other laboratory tests for detection of Chlamydia. Br J Ophthalmol (1971) 1.72
Identification of a regulatory region that mediates glucose-dependent induction of the Saccharomyces cerevisiae enolase gene ENO2. Mol Cell Biol (1986) 1.69
Safety and place of birth in Scotland. J Public Health Med (1995) 1.66
The role of the liver in immunity to blood-stage murine malaria. Immunology (1980) 1.65
Cell-mediated immunity in the liver of mice vaccinated against malaria. Nature (1979) 1.64
Choice and chance in low risk maternity care. BMJ (1991) 1.63
Cycle helmet wearing in teenagers--do health beliefs influence behaviour? Arch Dis Child (1994) 1.61
Estimating intrapartum-related perinatal mortality rates for booked home births: when the 'best' available data are not good enough. BJOG (2009) 1.61
Epidemiological and clinical features of primary herpes simplex virus ocular infection. Br J Ophthalmol (1985) 1.61
Characterization of human Mycobacterium bovis bacille Calmette-Guérin-reactive CD8+ T cells. Infect Immun (1999) 1.60
Human CD8+ CTL specific for the mycobacterial major secreted antigen 85A. J Immunol (2000) 1.58
Chlamydial serology. Br Med Bull (1983) 1.57
Prevalence in human beings of antibodies to Chlamydia IOL-207, an atypical strain of chlamydia. J Infect (1986) 1.56
Stimulation of human peripheral blood mononuclear cells with live Mycobacterium bovis BCG activates cytolytic CD8+ T cells in vitro. Immunology (1996) 1.54
Transcript quantitation in total yeast cellular RNA using kinetic PCR. Nucleic Acids Res (2000) 1.53
Nucleotide sequence and taxonomic value of the major outer membrane protein gene of Chlamydia pneumoniae IOL-207. J Gen Microbiol (1991) 1.53
What do young people want from their GP? Br J Gen Pract (1996) 1.52
Primary health care and adolescence. BMJ (1995) 1.52
Use of polymerase chain reaction to assess efficacy of leprosy chemotherapy. Lancet (1993) 1.52
Do we need specialist adolescent units in hospitals? BMJ (2001) 1.51
Isolation and characterization of yeast strains carrying mutations in the glyceraldehyde-3-phosphate dehydrogenase genes. J Biol Chem (1985) 1.51
Variations in policies for management of the third stage of labour and the immediate management of postpartum haemorrhage in Europe. BJOG (2007) 1.51
Colposcopy, biopsy, and cytology results in women with chlamydial cervicitis. Genitourin Med (1989) 1.48
Identifying problems with data collection at a local level: survey of NHS maternity units in England. BMJ (1999) 1.48
Perinatal health services: an immodest proposal. Br Med J (1980) 1.46
Interferon-gamma responses to ESAT-6 in tuberculosis patients early into and after anti-tuberculosis treatment. Int J Tuberc Lung Dis (2005) 1.46
Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-alpha) gene promoter and with elevated TNF-alpha levels in tear fluid. Infect Immun (1997) 1.45
Trachoma in South Africa. Soc Sci Med (1983) 1.41
Guinea-pig inclusion conjunctivitis as a model for the study of trachoma: clinical, microbiological, serological, and cytological studies of primary infection. Br J Ophthalmol (1980) 1.39
AIDS defining conditions in Africans resident in the United Kingdom. Int J STD AIDS (1996) 1.38
Infection by Bedsoniae and the possiblity of spurious isolation. I. Cross-infection of eggs during culture. Am J Ophthalmol (1967) 1.36
Infection by TRIC agent and other members of the Bedsonia group; with a note on Reiter's disease. 3. Genital infection and disease of the eye. Trans Ophthalmol Soc U K (1966) 1.35
'A time to die'? Int J Epidemiol (1984) 1.35
Micro-immunofluorescence type-specific serological tests for chlamydial infection applied to psittacosis, ornithosis, lymphogranuloma venereum, trachoma, paratrachoma and 'nonspecific' urethritis. Proc R Soc Med (1974) 1.35
Killing of the malarial parasite Plasmodium yoelii in vitro by cells of myeloid origin. Parasite Immunol (1982) 1.34
Development of a whole blood assay to measure T cell responses to leprosy: a new tool for immuno-epidemiological field studies of leprosy immunity. J Immunol Methods (1994) 1.33
RNA polymerase I-dependent selective transcription of yeast ribosomal DNA. Identification of a new cellular ribosomal RNA precursor. J Biol Chem (1983) 1.32
Jaagsiekte retrovirus establishes a disseminated infection of the lymphoid tissues of sheep affected by pulmonary adenomatosis. J Gen Virol (1996) 1.30
Risk factors for active trachoma in The Gambia. Trans R Soc Trop Med Hyg (2008) 1.29
Infection by TRIC agent and other members of the Bedsonia group; with a note on Reiter's disease. I. Ocular disease in the adult. Trans Ophthalmol Soc U K (1966) 1.28
Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative responses to chlamydial antigens compared with those of persistently diseased controls. Infect Immun (1995) 1.27
Evidence for naturally occurring recombination in the gene encoding the major outer membrane protein of lymphogranuloma venereum isolates of Chlamydia trachomatis. Infect Immun (1994) 1.27
Serotypes of Chlamydia trachomatis in The Gambia. Lancet (1987) 1.25
Epidemiology of infection by serotypes D to K of chlamydia trachomatis. Br J Vener Dis (1980) 1.25
Antichlamydial antibodies in pelvic inflammatory disease. Br J Vener Dis (1979) 1.25
The differentiation of Chlamydia species by antigen detection in sputum specimens from patients with community-acquired acute respiratory infections. J Infect (1992) 1.25
The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guérin vaccination in southern England and northern Malawi. Clin Exp Immunol (2006) 1.24
Sequences within the spacer region of yeast rRNA cistrons that stimulate 35S rRNA synthesis in vivo mediate RNA polymerase I-dependent promoter and terminator activities. Mol Cell Biol (1989) 1.24